Rohto Pharma (India) Private Limited, a active foreign private limited company, was established on 23 September 2010 in Galleria Dlf-Iv, Haryana, India. Engaging in cosmetics & makeup products within the trade sector, it holds CIN: U24100HR2010FTC053292. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹117.00 Cr and a paid-up capital of ₹116.50 Cr.
It upholds a compliant status. Employing 34 professional, Its leadership includes Koji Suzuki (Managing Director), Daiki Kato (Director). Past directors included Shingo Kuriyama, Koji Suzuki, Kunio Yamada. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Vo-029 At Wework Hq27, B-660, Sushant Lok Phase I, Sector 27, Galleria Dlf-Iv, Haryana, 122009.
U24100HR2010FTC053292
053292
23 September 2010
₹117.00 Cr
₹116.50 Cr
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Rohto Pharma (India) Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Koji Suzuki | Managing Director | 23 Sep 2010 | Current |
| Daiki Kato | Director | 05 Aug 2020 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Managing Director | 27 Jun 2016 | Past |
| Pramod Abcsdd | Director | 27 Jun 2016 | Past |
| Pramod Abcsdd | Director | 17 May 2014 | Past |
| Pramod Abcsdd | Additional Director | 24 Sep 2020 | Past |
| Pramod Abcsdd | Additional Director | 21 May 2014 | Past |
| Pramod Abcsdd | Company Secretary | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Rohto Pharma (India) Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 96.33% decrease. The company also saw a substantial improvement in profitability, with a 81.17% increase in profit. The company's net worth observed a substantial decline by a decrease of 230.45%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Rohto Pharma (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Rohto Pharma (India) has a workforce of 34 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Rohto Pharma (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rohto Pharma (India)'s trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Rohto Pharma (India) Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.
Progress on Rohto Pharma (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was documented.
The activity Supreet Kaur Rekhi was appointed as a Company Secretary was appointed as a Company Secretary on 26 Mar 2024 & has been associated with this company since 1 year 8 months . was completed.
Daiki Kato was appointed as a Director was appointed as a Director on 05 Aug 2020 & has been associated with this company since 5 years 3 months . was recorded as a recent event.
Progress on Koji Suzuki was appointed as a Managing Director was appointed as a Managing Director on 23 Sep 2010 & has been associated with this company since 15 years 2 months . was documented.
Rohto Pharma (India) Private Limited was registered on 23 Sep 2010 with Roc Delhi & aged 15 years 2 months as per MCA records. was recorded as a recent event.
The CIN of Rohto Pharma (India) Private Limited is U24100HR2010FTC053292.
Rohto Pharma (India) Private Limited is headquartered at Vo-029 At Wework Hq27, B-660, Sushant Lok Phase I, Sector 27, Galleria Dlf-Iv, Haryana, 122009.
Rohto Pharma (India) Private Limited was incorporated on 23 September 2010.
The current directors of Rohto Pharma (India) Private Limited are
The primary industry of Rohto Pharma (India) Private Limited is Trade.
Rohto Pharma (India) Private Limited is unlisted.
The authorized capital of Rohto Pharma (India) Private Limited is ₹117.00 Cr, and the paid-up capital is ₹116.50 Cr.
The compliance status of Rohto Pharma (India) Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX